(Prescription medicines only)
Dosage
Dosage
(For medical professions only)
Inflammatory and allergic disordersBy mouth, slow intravenous injection or by
intravenous infusion
Child 1 month–18 years
intravenous infusion
Child 1 month–18 years
0.5–1.7 mg/kg daily in 2–4 divided doses depending on condition and response.
Treatment of graft rejection reactionsBy intravenous injection
Child 1 month–18 years
Child 1 month–18 years
10–20 mg/kg or 400–600 mg/m2 (max. 1 g) once daily for 3 days
Severe erythema multiforme (Stevens-Johnson syndrome), lupus nephritis, systemic onset juvenile idiopathic arthritisBy intravenous injection
Child 1 month–18 years 10–30 mg/kg (max.
1 g) once daily or on alternate days for up to 3
doses
Child 1 month–18 years 10–30 mg/kg (max.
1 g) once daily or on alternate days for up to 3
doses
Brand names
Medrone (Pharmacia) Medrol
Medrone (Pharmacia) Medrol
Solu-Medrone (Pharmacia) Solu Medrol
Depo-Medrone (Pharmacia) Depo Medrol
Administration intravenous injection given over 30 minutes; for intravenous infusion may be diluted with sodium chloride intravenous infusion 0.9% or 0.45%, or glucose intravenous infusion 5% or 10%
Administration intravenous injection given over 30 minutes; for intravenous infusion may be diluted with sodium chloride intravenous infusion 0.9% or 0.45%, or glucose intravenous infusion 5% or 10%
By deep intramuscular injection into gluteal muscle
Other indications
- Adrenogenital Syndrome
- Allergic Rhinitis
- Asthma
- Asthma, acute
- Asthma, Maintenance
- Atopic Dermatitis
- Dermatologic Lesion
- Gout, Acute
- Immunosuppression
- Inflammatory Conditions
- Neuralgia
- Osteoarthritis
- Plaque Psoriasis
- Psoriasis
- Rheumatoid Arthritis
- Shock
- Transverse Myelitis
- the treatment of atopic dermatitis (endogenous eczema, neurodermatitis)
- eczema in children
- contact eczema
- degenerative, dyshidrotic or vulgar eczema.
Dosage
